Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 72

Sort by

Sort Order Select

Journal Articles

The Geriatric Syndrome of Sarcopenia Impacts Allogeneic Hematopoietic Cell Transplantation Outcomes in Combination with Multi-Morbidity and Functional Impairment

Richard J Lin, MD PhD, Laure Michaud, MD, Stephanie M Lobaugh, MS, Reiko Nakajima, MD, Theresa A Elko, MS, Josel D Ruiz, MPH, Craig S. Sauter, MD, Parastoo B. Dahi, MD, Molly A. Maloy, MS, Miguel-Angel Perales, MD, Soo Jung Kim, NP, Beatriz Korc-Grodzicki, MD PhD, Sean M. Devlin, PhD, Michael Scordo, MD, Heiko Schoder, MD, Sergio A Giralt, MD, Paul A. Hamlin, MD

Blood (2019) 134 (Supplement_1): 4508.

https://doi.org/10.1182/blood-2019-125141

Published: 2019

Journal Articles

Reduction of Vertebral Bone Density in Patients with Hodgkin Lymphoma Above 30 Years of Age Correlates with the Cumulative Dose of Steroids They Receive As Part of Treatment Protocol

Nadav Ofshenko, Eyal Bercovich, Tania Mashiach, Michal Weiler-Sagie, Daniela Militianu, Eldad J Dann, MD

Blood (2019) 134 (Supplement_1): 4042.

https://doi.org/10.1182/blood-2019-122675

Published: 2019

Journal Articles

Donor and Host Coexpressing KIR Ligands Promote NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Xingxing Yu, Xiang-Yu Zhao, Zhengli Xu, Xunhong Cao, Mingrui Huo, Xiao-Su Zhao, Ying-Jun Chang, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, MD

Blood (2019) 134 (Supplement_1): 4519.

https://doi.org/10.1182/blood-2019-129609

Published: 2019

Journal Articles

Discontinuation Patterns in Patients Receiving Novel Oral Agents for Chronic Lymphocytic Leukemia in the Veterans Health Administration

Hsu-Chih Chien, PhD MSc, Vikas Patil, MS, Kelli M Rasmussen, MS, Christina Yong, MA, Juliana M L Biondo, MD, Mary Halloran, PharmD, BCPS, Sheila Shapouri, PharmD, MS, Mei Wu, PharmD, Zachary R Burningham, PhD, Brian C Sauer, PhD, Ahmad S Halwani, MD

Blood (2019) 134 (Supplement_1): 4309.

https://doi.org/10.1182/blood-2019-128645

Published: 2019

Journal Articles

Hypoxia Dependent and Independent Dysregulation of the Transcriptome in Sickle Cell Anemia

Xu Zhang, PhD, Jihyun Song, PhD, Binal N. Shah, Taif Hassan, Galina Miasnikova, MD, Adelina Sergueeva, MD, Josef T. Prchal, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 2262.

https://doi.org/10.1182/blood-2019-132078

Published: 2019

Journal Articles

Maximizing FDG-PET/CT Utility in Staging of Follicular Lymphoma (FL): The Role of Spleen Involvement and Bone Standardized Uptake Values

Frederique St-Pierre, MD, Stephen Broski, MD, Betsy Laplant, MS, Thomas M. Habermann, MD, Thomas E. Witzig, MD

Blood (2019) 134 (Supplement_1): 2811.

https://doi.org/10.1182/blood-2019-131992

Published: 2019

Journal Articles

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Rafael Fonseca, MD, May Hagiwara, PhD, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Jacqueline Buchanan, Thomas Delea, MBA

Blood (2019) 134 (Supplement_1): 2211.

https://doi.org/10.1182/blood-2019-123743

Published: 2019

Journal Articles

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse

Ahmad S Halwani, MD, Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Vikas Patil, MS, Kelli M Rasmussen, MS, Catherine Li, PhD, Zachary R Burningham, PhD, Anthony S Masaquel, PhD MPH, Mary Halloran, PharmD, BCPS, Elisha Delong-Sieg, PharmD, Mathias Schulz, MD MBA, Jia Li, PhD, Brian C Sauer, PhD

Blood (2019) 134 (Supplement_1): 1622.

https://doi.org/10.1182/blood-2019-127719

Published: 2019

Journal Articles

Sequence of Second Generation Tyrosine Kinase Inhibitors (TKIs) in the Treatment of Patients with Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia - Real World Experience in the UK

Jenny Byrne, MD PhD, Joanne Ewing, PhDBMBS BSc FRPATH, Adam J. Mead, MD PhD, Heather Oakervee, BSc, MBBS, MD MRCP, FRCPath, Gavin Campbell, FRCP,FRCPath, Ian Amott, Andrew Goringe, Earnest Heartin, Evangelia Dimitriadou, MD, Ian Pamphlett, Siamak Arami, MD MRCP, FRCPath, Pratap Neelakantan, Rebecca Frewin, Srinivas Pillai, MBBS,MD MRCP, FRCPath, Hugues De Lavallade, Nicholas C.P. Cross, Michael Thompson

Blood (2019) 134 (Supplement_1): 3434.

https://doi.org/10.1182/blood-2019-122893

Published: 2019

Journal Articles

Costimulatory Molecule DNAM-1 Is Essential for Optimal NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Qiannan Shang, MBBS, Xingxing Yu, Xunhong Cao, Xuefei Liu, Zhengli Xu, Yingjun Chang, Xiaosu Zhao, PhD, Yu Wang, Xiaohui Zhang, MD, Lanping Xu, Xiaojun Huang, MD, Xiangyu Zhao

Blood (2019) 134 (Supplement_1): 3291.

https://doi.org/10.1182/blood-2019-130593

Published: 2019

Journal Articles

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Koji Nagafuji, MD PhD, Toshihiro Miyamoto, MD PhD, Tetsuya Eto, MD PhD, Ryosuke Ogawa, MD PhD, Naoyuki Uchida, MD PhD, Ken Takase, MD, Noriaki Kawano, MD PhD, Tomoaki Fujisaki, MD PhD, Tomohiko Kamimura, MD PhD, Atsushi Wake, MD PhD, Hirokazu Okumura, MD PhD, Yasuhiko Miyazaki, MD PhD, Yasushi Takamatsu, MD PhD, Toshiro Kurokawa, MD PhD, Yuju Ohno, MD PhD, Shouhei Yokota, MP.Path, Koichi Akashi, MD PhD

Blood (2018) 132 (Supplement 1): 3970.

https://doi.org/10.1182/blood-2018-99-112848

Published: 2018

Journal Articles

Unravelling the Heterogeneity of Mantle Cell Lymphoma Ecosystem By Single Cell RNA Sequencing

Makhdum Ahmed, MD PhD MPH, Hui Guo, PhD, Shaojun Zhang, PhD, Lalit Sehgal, PhD MPhil, Preetesh Jain, MBBS, MDDM, PhD, Rashmi Kanagal-Shamanna, MD, Chi Young Ok, MD, Angela Leeming, Yixin Yao, PhD, Liang Zhang, MD PhD, Krystle Nomie, PhD, Linghua Wang, PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 4118.

https://doi.org/10.1182/blood-2018-99-110540

Published: 2018

Journal Articles

TP53 Mutations Negatively Impact Survival of Acute Myeloid Leukemia Patients Treated with Standard Doses of Azacitidine

Pierre Bories, MD, Naïs Prade, Stéphanie Lagarde, Bastien Cabarrou, Julien Plenecassagnes, Isabelle Luquet, MD, Veronique De Mas, Thomas Filleron, PhD, Manon Cassou, Audrey Sarry, Luc Matthieu Fornecker, Célestine Simand, MD, Sarah Bertoli, MD PhD, Hinrich Gronemeyer, Christian Recher, MD PhD, Eric Delabesse, MD PhD

Blood (2018) 132 (Supplement 1): 2745.

https://doi.org/10.1182/blood-2018-99-117219

Published: 2018

Journal Articles

Association of Sarcopenia with Toxicities and Survival after Autologous Hematopoietic Stem Cell Transplantation for Adults with Lymphomas

Abel Costa Neto, MD, Bruna Del Guerra Carvalho Moraes, Ilanna Marques Gomes Rocha, Felipe Acquesta Bezerra, MD, Galtieri Otavio Cunha Medeiros, Lucas Bassolli Oliveira Alves, Renata Ariza Marques Rossetti, PhD, Ana Paula Trussardi Fayh, PhD, Livia Caroline Barbosa Mariano, MD, Vanderson Rocha, MD PhD

Blood (2018) 132 (Supplement 1): 2158.

https://doi.org/10.1182/blood-2018-99-117717

Published: 2018

Journal Articles

Depletion of Mature B Cells By Anti CD20-Directed Antibody Induces Trabecular Bone Loss in Young Mice: An Alert for Clinicians?

Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Alina Ostrovsky, Nathalie Ben-Califa, PhD, Sahar Hiram-Bab, PhD, Tamar Liron, PhD, Howard S. Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2017) 130 (Supplement 1): 5642.

https://doi.org/10.1182/blood.V130.Suppl_1.5642.5642

Published: 2017

Journal Articles

Longitudinal Changes in Body Composition Following Hematopoietic Cell Transplantation

Zachariah Defilipp, MD, Fabian M Troschel, David A Qualls, MD, Shuli Li, PhD, Maria Kempner, BA, Yi-Bin Chen, MD, Areej El-Jawahri, MD, Florian J Fintelmann

Blood (2017) 130 (Supplement 1): 4514.

https://doi.org/10.1182/blood.V130.Suppl_1.4514.4514

Published: 2017

Journal Articles

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Taiki Ando, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taisei Suzuki, MD, Hiroshi Teranaka, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD

Blood (2017) 130 (Supplement 1): 4562.

https://doi.org/10.1182/blood.V130.Suppl_1.4562.4562

Published: 2017

Journal Articles

Flow Cytometry Immunophemotyping Evaluation in the Diagnosis of Acute Lymphoblastic Leukemia in Patients from Rio Grande Do Norte State, Brazil

Gabriela VA Alves, PhD, Aldair Paiva, MD, Valéria SF Sales, PhD, Dany GKC Silva, Irian G Farkatt, Edvis Santos Soares Serafim, MD, Lavoisier C Silva, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2017) 130 (Supplement 1): 5116.

https://doi.org/10.1182/blood.V130.Suppl_1.5116.5116

Published: 2017

Journal Articles

Genomic Characteristics Clinical Phenotype and Disease Course of TP53 Mutated Diffuse Large B Cell Lymphoma at Diagnosis and Relapse

Blood (2017) 130 (Supplement 1): 1460.

https://doi.org/10.1182/blood.V130.Suppl_1.1460.1460

Published: 2017

Journal Articles

Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma

Hiroshi Teranaka, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taiki Ando, MD, Taisei Suzuki, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD

Blood (2017) 130 (Supplement 1): 5221.

https://doi.org/10.1182/blood.V130.Suppl_1.5221.5221

Published: 2017

NARROW

The Geriatric Syndrome of Sarcopenia Impacts Allogeneic Hematopoietic Cell Transplantation Outcomes in Combination with Multi-Morbidity and Functional Impairment

Reduction of Vertebral Bone Density in Patients with Hodgkin Lymphoma Above 30 Years of Age Correlates with the Cumulative Dose of Steroids They Receive As Part of Treatment Protocol

Donor and Host Coexpressing KIR Ligands Promote NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Discontinuation Patterns in Patients Receiving Novel Oral Agents for Chronic Lymphocytic Leukemia in the Veterans Health Administration

Hypoxia Dependent and Independent Dysregulation of the Transcriptome in Sickle Cell Anemia

Maximizing FDG-PET/CT Utility in Staging of Follicular Lymphoma (FL): The Role of Spleen Involvement and Bone Standardized Uptake Values

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse

Sequence of Second Generation Tyrosine Kinase Inhibitors (TKIs) in the Treatment of Patients with Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia - Real World Experience in the UK

Costimulatory Molecule DNAM-1 Is Essential for Optimal NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Unravelling the Heterogeneity of Mantle Cell Lymphoma Ecosystem By Single Cell RNA Sequencing

TP53 Mutations Negatively Impact Survival of Acute Myeloid Leukemia Patients Treated with Standard Doses of Azacitidine

Association of Sarcopenia with Toxicities and Survival after Autologous Hematopoietic Stem Cell Transplantation for Adults with Lymphomas

Depletion of Mature B Cells By Anti CD20-Directed Antibody Induces Trabecular Bone Loss in Young Mice: An Alert for Clinicians?

Longitudinal Changes in Body Composition Following Hematopoietic Cell Transplantation

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Flow Cytometry Immunophemotyping Evaluation in the Diagnosis of Acute Lymphoblastic Leukemia in Patients from Rio Grande Do Norte State, Brazil

Genomic Characteristics Clinical Phenotype and Disease Course of TP53 Mutated Diffuse Large B Cell Lymphoma at Diagnosis and Relapse

Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only